Loading live market data…

Protagonist Therapeutics, Inc.

NASDAQ:PTGX

$136.1364 USD

$4.87 (3.71%)

Volume
224.18K
Average Volume
722.65K
Market Capitalization
$8.76B
P/E Ratio
-75.55
Dividend Yield
0.00%
Price Target
$121.00
Year High
$141.10
Year Low
$50.49
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$17.76

PTGX Estimated and Actual Revenue by Quarter

PTGX Estimated and Actual EPS by Quarter

PTGX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 -48.07M -25.63M -41.13M -48.1M -25.65M -41.15M
2027-09-30 2 -27.08M -14.44M -23.17M -27.1M -14.45M -23.18M
2027-06-30 2 -23.42M -12.49M -20.04M -23.43M -12.5M -20.05M
2027-03-31 2 -22.17M -11.82M -18.97M -22.18M -11.83M -18.98M
2026-12-31 2 -56.01M -29.87M -47.93M -56.05M -29.89M -47.96M
2026-09-30 5 -132.54M -127.21M -130.04M -132.61M -127.28M -130.11M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 7.73M 18.48M 15.16M 29.2M 54.75M 46.85M
2027-09-30 2 -12.16M -5.09M -9.97M 16.45M 30.84M 26.39M
2027-06-30 2 -17.21M -7.2M -14.12M 14.22M 26.68M 22.82M
2027-03-31 2 -19.67M -8.23M -16.13M 13.47M 25.25M 21.61M
2026-12-31 2 5.36M 12.8M 10.5M 34.02M 63.8M 54.59M
2026-09-30 5 -27.46M 215.52M 135.9M 144.89M 150.95M 148.11M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 38.2M 71.64M 61.3M 2 0.10969 0.26215 0.215
2027-09-30 2 21.52M 40.36M 34.53M 2 -0.17253 -0.07219057 -0.1415
2027-06-30 2 18.61M 34.91M 29.87M 2 -0.24417 -0.10216 -0.20025
2027-03-31 2 17.62M 33.04M 28.27M 2 -0.27898 -0.11673 -0.2288
2026-12-31 2 44.52M 83.48M 71.43M 4 0.07597101 0.18157 0.14891
2026-09-30 5 189.59M 197.52M 193.8M 6 -0.38948 3.05741 1.92792